US FDA approves Lilly's Mounjaro to reduce cardiovascular risk - Reuters
The story
- US FDA approves Lilly's Mounjaro to reduce cardiovascular risk Reuters
- FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes Eli Lilly and Company
- Eli Lilly's diabetes drug Mounjaro gets approval for a new use USA Today
- Lilly Diabetes Shot Mounjaro Wins US Approval for Heart Disease Bloomberg.com
- Eli Lilly's diabetes drug wins FDA approval to lower heart attack and stroke risk qz.com
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
How other outlets covered this
Compare allAlto found this story at 2 outlets. Same event, different framing — compare the headlines.
How this story developed
Full timelineAlto has tracked this across 2 days of coverage from 2 outlets.
- US FDA approves Lilly's Mounjaro to reduce cardiovascular risk - ReutersYou are here
Powered by Gab AI
The Story At A Glance
Reading this article now — analysis appears below
💡 AI analysis provides alternative perspectives on current events